期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 23, 期 4, 页码 965-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2009.06.010
关键词
Gram positive bacteria; Vancomycin; Daptomycin; Linezolid; Quinupristin; Dalfopristin; MRSA; VRE
An overview of the mechanism of action, dosing, clinical indications, and toxicities of the glycopeptide vancomycin is provided. The emerging gram-positive bacterial resistance to antimicrobials and its mechanisms are reviewed. Strategies to control this emergence of resistance are expected to be proposed. Newer antimicrobial agents that have activity against vancomycin-resistant organisms are now available and play a critical role in the treatment of life-threatening infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据